Your browser doesn't support javascript.
loading
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.
Pennig, Jan; Scherrer, Philipp; Gissler, Mark Colin; Anto-Michel, Nathaly; Hoppe, Natalie; Füner, Lisa; Härdtner, Carmen; Stachon, Peter; Wolf, Dennis; Hilgendorf, Ingo; Mullick, Adam; Bode, Christoph; Zirlik, Andreas; Goldberg, Ira J; Willecke, Florian.
Afiliação
  • Pennig J; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Scherrer P; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Gissler MC; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Anto-Michel N; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Hoppe N; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Füner L; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Härdtner C; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Stachon P; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Wolf D; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Hilgendorf I; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Mullick A; Ionis Pharmaceuticals, Carlsbad, California, USA.
  • Bode C; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Zirlik A; University Heart Center Freiburg-Bad Krozingen, Cardiology and Angiology I, University of Freiburg, Freiburg, Germany.
  • Goldberg IJ; Division of Cardiology, Medical University of Graz, Graz, Austria.
  • Willecke F; Department of Medicine, New York University Langone Health, New York, NY, USA.
Sci Rep ; 9(1): 17937, 2019 11 29.
Article em En | MEDLINE | ID: mdl-31784656
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Experimental / Aterosclerose / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Experimental / Aterosclerose / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha